These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28397447)

  • 1. Campylobacter concisus as the etiologic agent of gastrointestinal diseases.
    Akutko K; Matusiewicz K
    Adv Clin Exp Med; 2017; 26(1):149-154. PubMed ID: 28397447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Campylobacter Concisus and Its Effect on the Expression of CDX1 and COX2.
    Mozaffari Namin B; Soltan Dallal MM
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3211-3216. PubMed ID: 30486614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptomic and proteomic analyses reveal key innate immune signatures in the host response to the gastrointestinal pathogen Campylobacter concisus.
    Kaakoush NO; Deshpande NP; Man SM; Burgos-Portugal JA; Khattak FA; Raftery MJ; Wilkins MR; Mitchell HM
    Infect Immun; 2015 Feb; 83(2):832-45. PubMed ID: 25486993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of inflammatory bowel disease after
    Nielsen HL; Dalager-Pedersen M; Nielsen H
    Scand J Gastroenterol; 2019 Mar; 54(3):265-272. PubMed ID: 30905214
    [No Abstract]   [Full Text] [Related]  

  • 5. Motility and biofilm formation of the emerging gastrointestinal pathogen Campylobacter concisus differs under microaerophilic and anaerobic environments.
    Ovesen S; Durack J; Kirk KF; Nielsen HL; Nielsen H; Lynch SV
    Gut Microbes; 2019; 10(1):34-44. PubMed ID: 30252590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic potential of
    Kato I; Minkevitch J; Sun J
    Scand J Gastroenterol; 2023; 58(12):1453-1465. PubMed ID: 37366241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The susceptibility of Campylobacter concisus to the bactericidal effects of normal human serum.
    Kirk KF; Nielsen HL; Nielsen H
    APMIS; 2015 Mar; 123(3):269-74. PubMed ID: 25627875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Clinical Importance of
    Liu F; Ma R; Wang Y; Zhang L
    Front Cell Infect Microbiol; 2018; 8():243. PubMed ID: 30087857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical manifestations of Campylobacter concisus infection in children.
    Nielsen HL; Engberg J; Ejlertsen T; Nielsen H
    Pediatr Infect Dis J; 2013 Nov; 32(11):1194-8. PubMed ID: 23743545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Campylobacter concisus - A new player in intestinal disease.
    Kaakoush NO; Mitchell HM
    Front Cell Infect Microbiol; 2012; 2():4. PubMed ID: 22919596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motility of Campylobacter concisus isolated from saliva, feces, and gut mucosal biopsies.
    Ovesen S; Kirk KF; Nielsen HL; Nielsen H
    APMIS; 2017 Mar; 125(3):230-235. PubMed ID: 28116789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of emerging Campylobacter species in inflammatory bowel diseases.
    Kaakoush NO; Mitchell HM; Man SM
    Inflamm Bowel Dis; 2014 Nov; 20(11):2189-97. PubMed ID: 24874462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohn's disease.
    Man SM; Zhang L; Day AS; Leach ST; Lemberg DA; Mitchell H
    Inflamm Bowel Dis; 2010 Jun; 16(6):1008-16. PubMed ID: 19885905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term and medium-term clinical outcomes of Campylobacter concisus infection.
    Nielsen HL; Engberg J; Ejlertsen T; Bücker R; Nielsen H
    Clin Microbiol Infect; 2012 Nov; 18(11):E459-65. PubMed ID: 22882347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delineation of Campylobacter concisus genomospecies by amplified fragment length polymorphism analysis and correlation of results with clinical data.
    Aabenhus R; On SL; Siemer BL; Permin H; Andersen LP
    J Clin Microbiol; 2005 Oct; 43(10):5091-6. PubMed ID: 16207968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Campylobacter species: Initiators of a subgroup of inflammatory bowel disease?
    Zhang L
    World J Gastroenterol; 2015 Aug; 21(31):9239-44. PubMed ID: 26309350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-directed mutagenesis of Campylobacter concisus respiratory genes provides insight into the pathogen's growth requirements.
    Benoit SL; Maier RJ
    Sci Rep; 2018 Sep; 8(1):14203. PubMed ID: 30242194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative genomics of Campylobacter concisus: Analysis of clinical strains reveals genome diversity and pathogenic potential.
    Gemmell MR; Berry S; Mukhopadhya I; Hansen R; Nielsen HL; Bajaj-Elliott M; Nielsen H; Hold GL
    Emerg Microbes Infect; 2018 Jun; 7(1):116. PubMed ID: 29946138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome analysis of Campylobacter concisus strains from patients with inflammatory bowel disease and gastroenteritis provides new insights into pathogenicity.
    Chung HK; Tay A; Octavia S; Chen J; Liu F; Ma R; Lan R; Riordan SM; Grimm MC; Zhang L
    Sci Rep; 2016 Dec; 6():38442. PubMed ID: 27910936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of complete
    Liu F; Chen S; Luu LDW; Lee SA; Tay ACY; Wu R; Riordan SM; Lan R; Liu L; Zhang L
    Microb Genom; 2020 Nov; 6(11):. PubMed ID: 33111662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.